Previous Article | Next Article 
Infection and Immunity, June 2006, p. 3381-3386, Vol. 74, No. 6
0019-9567/06/$08.00+0 doi:10.1128/IAI.00185-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Gamma Interferon, Tumor Necrosis Factor Alpha, and Nitric Oxide Synthase 2, Key Elements of Cellular Immunity, Perform Critical Protective Functions during Humoral Defense against Lethal Pulmonary Yersinia pestis Infection
Michelle A. Parent,
Lindsey B. Wilhelm,
Lawrence W. Kummer,
Frank M. Szaba,
Isis K. Mullarky, and
Stephen T. Smiley*
Trudeau Institute, Saranac Lake, New York
Received 2 February 2006/
Returned for modification 10 March 2006/
Accepted 17 March 2006
Pulmonary infection by Yersinia pestis causes pneumonic plague, a rapidly progressing and often fatal disease. To aid the development of safe and effective pneumonic plague vaccines, we are deciphering mechanisms used by the immune system to protect against lethal pulmonary Y. pestis infection. In murine pneumonic plague models, passive transfer of convalescent-phase sera confers protection, as does active vaccination with live Y. pestis. Here, we demonstrate that protection by either protocol relies upon both gamma interferon (IFN-
) and tumor necrosis factor alpha (TNF-
) cytokines classically associated with type 1 cellular immunity. In both protocols, abrogating IFN-
or TNF-
activity significantly decreases survival and increases the bacterial burden in pulmonary, splenic, and hepatic tissues. Neutralization of either cytokine also counteracts challenge-induced, vaccination-dependent upregulation of nitric oxide synthase 2 (NOS2). Moreover, genetic depletion of NOS2 suppresses protection conferred by serotherapy. We conclude that IFN-
, TNF-
, and NOS2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Y. pestis challenge. These observations strongly suggest that plague vaccines should strive to maximally prime both cellular and humoral immunity.
* Corresponding author. Mailing address: Trudeau Institute, 154 Algonquin Avenue, Saranac Lake, NY 12983. Phone: (518) 891-3080. Fax: (518) 891-5126. E-mail:
ssmiley{at}trudeauinstitute.org.
Editor: D. L. Burns
Infection and Immunity, June 2006, p. 3381-3386, Vol. 74, No. 6
0019-9567/06/$08.00+0 doi:10.1128/IAI.00185-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Yamanaka, H., Hoyt, T., Yang, X., Golden, S., Bosio, C. M., Crist, K., Becker, T., Maddaloni, M., Pascual, D. W.
(2008). A Nasal Interleukin-12 DNA Vaccine Coexpressing Yersinia pestis F1-V Fusion Protein Confers Protection against Pneumonic Plague. Infect. Immun.
76: 4564-4573
[Abstract]
[Full Text]
-
Lilo, S., Zheng, Y., Bliska, J. B.
(2008). Caspase-1 Activation in Macrophages Infected with Yersinia pestis KIM Requires the Type III Secretion System Effector YopJ. Infect. Immun.
76: 3911-3923
[Abstract]
[Full Text]
-
Zhang, Y., Murtha, J., Roberts, M. A., Siegel, R. M., Bliska, J. B.
(2008). Type III Secretion Decreases Bacterial and Host Survival following Phagocytosis of Yersinia pseudotuberculosis by Macrophages. Infect. Immun.
76: 4299-4310
[Abstract]
[Full Text]
-
Airhart, C. L., Rohde, H. N., Bohach, G. A., Hovde, C. J., Deobald, C. F., Lee, S. S., Minnich, S. A.
(2008). Induction of innate immunity by lipid A mimetics increases survival from pneumonic plague. Microbiology
154: 2131-2138
[Abstract]
[Full Text]
-
Li, B., Yang, R.
(2008). Interaction between Yersinia pestis and the Host Immune System. Infect. Immun.
76: 1804-1811
[Full Text]
-
Philipovskiy, A. V., Smiley, S. T.
(2007). Vaccination with Live Yersinia pestis Primes CD4 and CD8 T Cells That Synergistically Protect against Lethal Pulmonary Y. pestis Infection. Infect. Immun.
75: 878-885
[Abstract]
[Full Text]